Scholarly Index
Desmond Curran
GlaxoSmithKline (Belgium); 10,731 total citations; 231 total publications; best world rank #3
GlaxoSmithKline (Belgium)
10,731Total citations
231Total publications
43H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Herpesvirus Infections and Treatments | Lifetime | 545 | BE 11 | 97.41 |
| Acne and Rosacea Treatments and Effects | Lifetime | 115 | BE 2 | 97.47 |
| Bartonella species infections research | Lifetime | 139 | BE 3 | 91.53 |
| Herpesvirus Infections and Treatments | 2021-2025 | 31 | BE 1 | 97.44 |
| Bartonella species infections research | 2021-2025 | 3 | BE 1 | 96.24 |
| Acne and Rosacea Treatments and Effects | 2021-2025 | 28 | BE 1 | 96.68 |
| Cytomegalovirus and herpesvirus research | 2021-2025 | 301 | BE 8 | 88.38 |
| Vector-borne infectious diseases | 2021-2025 | 334 | BE 4 | 90.92 |
| Virology and Viral Diseases | 2021-2025 | 844 | BE 11 | 68.94 |
| Healthcare and Venom Research | 2021-2025 | 905 | BE 4 | 50.41 |